These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32424548)

  • 1. Longitudinal metabolic profiling of cardiomyocytes derived from human-induced pluripotent stem cells.
    Bekhite MM; González Delgado A; Menz F; Kretzschmar T; Wu JMF; Bekfani T; Nietzsche S; Wartenberg M; Westermann M; Greber B; Schulze PC
    Basic Res Cardiol; 2020 May; 115(4):37. PubMed ID: 32424548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes.
    Horikoshi Y; Yan Y; Terashvili M; Wells C; Horikoshi H; Fujita S; Bosnjak ZJ; Bai X
    Cells; 2019 Sep; 8(9):. PubMed ID: 31533262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells.
    Kikuchi C; Bienengraeber M; Canfield S; Koopmeiner A; Schäfer R; Bosnjak ZJ; Bai X
    Cell Transplant; 2015; 24(12):2491-504. PubMed ID: 25562386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.
    Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ
    Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage-free iPS cells exhibit potential to yield competent cardiomyocytes.
    Miller JM; Mardhekar NM; Pretorius D; Krishnamurthy P; Rajasekaran NS; Zhang J; Kannappan R
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H801-H815. PubMed ID: 32057252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid metabolism driven mitochondrial bioenergetics promotes advanced developmental phenotypes in human induced pluripotent stem cell derived cardiomyocytes.
    Ramachandra CJA; Mehta A; Wong P; Ja KPMM; Fritsche-Danielson R; Bhat RV; Hausenloy DJ; Kovalik JP; Shim W
    Int J Cardiol; 2018 Dec; 272():288-297. PubMed ID: 30177232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
    Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes.
    Gao Y; Su L; Wei Y; Tan S; Hu Z; Tao Z; Kovalik JP; Soong TW; Zhang J; Pu J; Ye L
    Theranostics; 2023; 13(11):3872-3896. PubMed ID: 37441603
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward Cardiomyocytes.
    Kawamura T; Miyagawa S; Fukushima S; Kashiyama N; Kawamura A; Ito E; Saito A; Maeda A; Eguchi H; Toda K; Miyagawa S; Okuyama H; Sawa Y
    Stem Cells Transl Med; 2015 Nov; 4(11):1258-64. PubMed ID: 26378261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform.
    Lodrini AM; Barile L; Rocchetti M; Altomare C
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
    Parveen S; Singh SP; Panicker MM; Gupta PK
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system.
    Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K
    Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin.
    Lewandowski J; Rozwadowska N; Kolanowski TJ; Malcher A; Zimna A; Rugowska A; Fiedorowicz K; Łabędź W; Kubaszewski Ł; Chojnacka K; Bednarek-Rajewska K; Majewski P; Kurpisz M
    Cell Transplant; 2018 Jul; 27(7):1047-1067. PubMed ID: 29947252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells.
    Yoshida S; Miyagawa S; Fukushima S; Kawamura T; Kashiyama N; Ohashi F; Toyofuku T; Toda K; Sawa Y
    Mol Ther; 2018 Nov; 26(11):2681-2695. PubMed ID: 30217728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus.
    Tang L; Wang H; Dai B; Wang X; Zhou D; Shen J; Guo F; Wang J; Zhou J; Wang H; Wu Q; Yao H; Gong T; Su J; Meng ZX; Niu T; Zhang L; Liang P
    J Mol Cell Cardiol; 2020 May; 142():53-64. PubMed ID: 32251671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes.
    Lee JJ; Cheng SJ; Huang CY; Chen CY; Feng L; Hwang DY; Kamp TJ; Chen HC; Hsieh PCH
    EBioMedicine; 2019 Feb; 40():675-684. PubMed ID: 30639418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Gentillon C; Li D; Duan M; Yu WM; Preininger MK; Jha R; Rampoldi A; Saraf A; Gibson GC; Qu CK; Brown LA; Xu C
    J Mol Cell Cardiol; 2019 Jul; 132():120-135. PubMed ID: 31082397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome-Dependent Regulation of Distinct Metabolic States During Long-Term Culture of Human iPSC-Derived Cardiomyocytes.
    Ebert A; Joshi AU; Andorf S; Dai Y; Sampathkumar S; Chen H; Li Y; Garg P; Toischer K; Hasenfuss G; Mochly-Rosen D; Wu JC
    Circ Res; 2019 Jun; 125(1):90-103. PubMed ID: 31104567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation.
    Jung G; Fajardo G; Ribeiro AJ; Kooiker KB; Coronado M; Zhao M; Hu DQ; Reddy S; Kodo K; Sriram K; Insel PA; Wu JC; Pruitt BL; Bernstein D
    FASEB J; 2016 Apr; 30(4):1464-79. PubMed ID: 26675706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.